IA
BHVN

IFP Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

IFP Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$1K – 4706
2022
Q4 		$1K Sell
1
-4
-80% -$607 ﹤0.01% 4585
2022
Q3 		$2K Hold
5
– – ﹤0.01% 4487
2022
Q2 		$2K Hold
5
– – ﹤0.01% 4265
2022
Q1 		$2K Buy
+5
New +$624 ﹤0.01% 4263
2021
Q1 		– Sell
-28
Closed -$2.27K – 3382
2020
Q4 		$2K Hold
28
– – ﹤0.01% 2696
2020
Q3 		$2K Hold
28
– – ﹤0.01% 2564
2020
Q2 		$2K Buy
+28
New +$1.49K ﹤0.01% 2469
2019
Q1 		– Sell
-12
Closed – – 4032
2018
Q4 		$0 Hold
12
– – ﹤0.01% 4148
2018
Q3 		$0 Hold
12
– – ﹤0.01% 4217
2018
Q2 		$0 Hold
12
– – ﹤0.01% 4312
2018
Q1 		$0 Hold
12
– – ﹤0.01% 3946
2017
Q4 		$0 Hold
12
– – ﹤0.01% 4451
2017
Q3 		$0 Buy
+12
New +$364 ﹤0.01% 4453

Other funds holding BHVN

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

IFP Advisors's BHVN Position: Q1 2023 in Review

IFP Advisors sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2023, closing a stake of 1 share — an estimated $1K sold.

IFP Advisors first reported a position in BHVN in Q3 2017 and held it in 13 quarters. The position peaked at $2K in Q3 2022. 2 funds tracked by Wall St. Rank hold BHVN as of Q1 2023.

  • IFP Advisors reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 1 Biohaven Pharmaceutical Holding Company Ltd. share in Q1 2023, an estimated $1K.
  • IFP Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 13 quarters.
  • IFP Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.